A homozygous MYBPC3 mutation can cause unexpected skeletal myopathy in addition to fatal cardiomyopathy due to aberrant expression of the mutant cardiac isoform in skeletal muscle.
No takes yet. Share an insight, caveat, or question.
May warrant screening for skeletal myopathy in MYBPC3 cardiomyopathy; leaves open broader phenotypic spectrum.
Tajsharghi et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: